Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease
- PMID: 25651439
- PMCID: PMC12877530
- DOI: 10.1007/s12603-014-0565-6
Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease
Abstract
Background: Non-pharmacological interventions may improve cognition and quality of life, reduce disruptive behaviors, slow progression from Mild Cognitive Impairment (MCI) to dementia, and delay institutionalization. It is important to look at their trial designs as well as outcomes to understand the state of the evidence supporting non-pharmacological interventions in Alzheimer's disease (AD). An analysis of trial design strengths and limitations may help researchers clarify treatment effect and design future studies of non-pharmacological interventions for MCI related to AD.
Methods: A systematic review of the methodology of Randomized Controlled Trials (RCTs) targeting physical activity, cognitive interventions, and socialization among subjects with MCI in AD reported until March 2014 was undertaken. The primary outcome was CONSORT 2010 reporting quality. Secondary outcomes were qualitative assessments of specific methodology problems.
Results: 23 RCT studies met criteria for this review. Eight focused on physical activity, fourteen on cognitive interventions, and one on the effects of socialization. Most studies found a benefit with the intervention compared to control. CONSORT reporting quality of physical activity interventions was higher than that of cognitive interventions. Reporting quality of recent studies was higher than older studies, particularly with respect to sample size, control characteristics, and methodology of intervention training and delivery. However, the heterogeneity of subjects identified as having MCI and variability in interventions and outcomes continued to limit generalizability.
Conclusions: The role for non-pharmacological interventions targeting MCI is promising. Future studies of RCTs for non-pharmacological interventions targeting MCI related to AD may benefit by addressing design limitations.
Figures
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th. American Psychiatric Publishing; Arlington, VA: 2013. 10.1176/appi.books.9780890425596 - DOI
-
- Mitchell A.J., Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119(4):252–265. 10.1111/j.1600-0447.2008.01326.x PubMed PMID: 19236314. - DOI - PubMed
-
- Phelan E.A., Borson S., Grothaus L., Balch S., Larson E.B. Association of incident dementia with hospitalizations. JAMA. 2012;307(2):165–172. 10.1001/jama.2011.1964 PMCID 3312921; PubMed PMID: 22235087. - DOI - PMC - PubMed
-
- Maslow K. Dementia and serious coexisting medical conditions: a double whammy. Nurs Clin North Am. 2004;39(3):561–579. 10.1016/j.cnur.2004.02.011 PubMed PMID: 15331302. - DOI - PubMed
-
- Pinquart M., Sorensen S. Helping caregivers of persons with dementia: which interventions work and how large are their effects. Int Psychogeriatr. 2006;18(4):577–595. 10.1017/S1041610206003462 PubMed PMID: 16686964. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
